SGLT2 Inhibitors for Type 2 Diabetes Mellitus Treatment

SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A(1c)-lowering effects while inducing weight loss without hypoglycemia.

Shranjeno v:
Bibliografske podrobnosti
izdano v:Fed Pract
Main Authors: Plodkowski, Raymond A., McGarvey, Megan E., Huribal, Heather M., Reisinger-Kindle, Keith, Kramer, Bradley, Solomon, Mordecai, Nguyen, Quang T.
Format: Artigo
Jezik:Inglês
Izdano: Frontline Medical Communications Inc. 2015
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6375399/
https://ncbi.nlm.nih.gov/pubmed/30766102
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki